KALV icon

KalVista Pharmaceuticals

26 hedge funds and large institutions have $51.3M invested in KalVista Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$447K
2 +$178K
3 +$108K
4
BlackRock
BlackRock
New York
+$88.6K
5
DS
DRW Securities
Illinois
+$45.4K

Top Sellers

1 -$1.76M
2 -$385K
3 -$146K
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$111K
5
Renaissance Technologies
Renaissance Technologies
New York
-$62.5K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$20.9M
2
$11.7M
3
$7.31M
4
$2.68M
5
$2.61M
6
$2.44M
7
$954K
8
$545K
9
$447K
10
$333K
11
$290K
12
$205K
13
$168K
14
$167K
15
$132K
16
$108K
17
$107K
18
$59K
19
$37K
20
$25K
21
$8K
22
$6K
23
$3K
24
$2K
25
$2K